June 29, 2022 /PRNewswire/
-- Mentice, Gothenburg (STO:
MNTC), a world leader in simulation solutions for image-guided
interventional therapies, announced today that Medtronic,
Dublin (NYSE: MDT), a global
healthcare technology leader, has signed an agreement to acquire
Mentice VIST® simulation solutions and development services, in an
initial order of USD 1.93 million.
The initial order includes the development services and 10
simulation solutions for delivery in 2022 raising to an additional
intention of 150 simulation solutions over 3 years.
"This agreement is, of course, an important commitment from
Medtronic as the world's largest Medical device manufacturer though
also to drive proficiency for physicians with aim of ultimately
improving patient outcomes" says Göran Malmberg, CEO and Group
President for Mentice, "this continues to underline our position as
the leading provider of performance solutions for Image guided
interventional therapies" Malmberg continues.
For further information, please contact:
Göran Malmberg, CEO, Mentice
Tel US: +1 (312) 860 5610
Tel Sweden: +46 (0) 703 09 22 22
This information was brought to you by Cision
The following files are available for download: